Dr. Agarwal's Health Care shareholding pattern

·Pharma & Health Chart ›

Who owns itSep 2026 quarter

Promoters32.33%−0.01 pts

Foreign investors (FII)49.56%−8.40 pts

Domestic institutions (DII)15.87%+8.15 pts

of which mutual funds14.18%+8.16 pts

of which insurance companies1.06%

Public2.24%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AGARWALEYE₹488.70

Dr. Agarwal's Health Care Ltd.

· Pharma & Health

₹ CrorePeersAKUMS ADVENZYMES ALIVUS AARTIPHARM AARTIDRUGS APLLTD CORONA HCGMcap ₹15,482 Cr

Holding % of Total Shares 12 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Promoter & Group	32.45	32.42	32.42	32.39	32.36	32.34	32.33
FII / FPI	60.62	59.26	58.13	58.06	57.94	57.96	49.56
DII	5.21	6.44	7.92	7.78	7.83	7.72	15.87
Mutual Funds	3.84	4.91	5.85	5.77	5.87	6.02	14.18

Latest: 2026-09-30 · 8 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.